On October 19, 2022, U.S. District Judge Mitchell Goldberg in the Eastern District of Pennsylvania granted Aquestive Therapeutics Inc.’s (f/k/a MonoSol Rx LLC) motion for summary judgment in the ...
The AGs had claimed that Invidior used 'product hopping' to block competition from generics for its opioid treatment drug. Drugmaker Invidior PLC says it will pay $102.5 million to 41 states and the ...
Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Click to email a link to a friend (Opens in new window) Click to share on LinkedIn (Opens in new window) ...
Rhode Island Attorney General Peter Neronha announced on Monday that the state would receive $5.4 million as its share of a $700 million settlement reached last week between consumer goods company ...
Hi-Tech Pharmacal Co., Inc. announced that the company will market buprenorphine HCl 2mg and 8mg sublingual tablets, the generic for Reckitt Benckiser's Subutex sublingual tablets through its ...
Buprenorphine is a prescription medication. It’s approved by the Food and Drug Administration (FDA) to treat opioid dependence in adults. Opioid dependence is also called opioid use disorder (OUD), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results